Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (4): 123-127.doi: 10.6040/j.issn.1671-7554.0.2021.1474
REN Hong, WANG Wei, LIN Yan, LOU Jianwei, JI Kunqian, ZHAO Yuying, YAN Chuanzhu
CLC Number:
[1] Vreken P, Valianpour F, Nijtmans LG, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome [J]. Biochem Biophys Res Commun, 2000, 279(2): 378-382. [2] Miller PC, Ren M, Schlame M, et al. A bayesian analysis to determine the prevalence of Barth syndrome in the pediatric population [J]. J Pediatr, 2020, 217: 139-144. doi: 10.1016/j.jpeds.2019.09.074. [3] Clarke SL, Bowron A, Gonzalez IL, et al. Barth syndrome [J]. Orphanet J Rare Dis, 2013, 8: 23. doi: 10.1186/1750-1172-8-23. [4] 宋金青, 马艳艳, 丁圆, 等. Barth综合征导致幼儿心内膜弹力纤维增生症的临床特点及其TAZ基因突变[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(5): 535-539. SONG Jinqing, MA Yanyan, DING Yuan, et al. Clinicai characteristics and TAZgene mutation of an infant with endocardial fibroelastosis due to Barth syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(5): 535-539. [5] Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases [J]. Circulation, 1990, 82(2): 507-513. [6] Roberts AE, Nixon C, Steward CG, et al. The Barth syndrome registry: distinguishing disease characteristics and growth data from a longitudinal study [J]. Am J Med Genet a, 2012, 158A(11): 2726-2732. [7] 石琳, 傅立军, 黄美容, 等. Barth综合征3例临床表现及基因突变分析[J]. 临床儿科杂志, 2015, 33(7): 614-617. [8] Schlame M, Xu Y. The Function of tafazzin, a mitochondrial phospholipid-lysophospholipid acyltransferase [J]. J Mol Biol, 2020, 432(18): 5043-5051. [9] Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism [J]. Cell Mol Life Sci, 2008, 65(16): 2493-2506. [10] Takeda A, Sudo A, Yamada M, et al. Eponym: Barth syndrome [J]. Eur J Pediatr, 2011, 170(11):1365-1367. [11] Aprikyan AA, Khuchua Z. Advances in the understanding of Barth syndrome [J]. Br J Haematol, 2013, 161(3): 330-338. [12] Zegallai HM, Hatch GM. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets [J]. Mol Cell Biochem, 2021, 476(3): 1605-1629. [13] Dudek J, Cheng IF, Chowdhury A, et al. Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome [J]. EMBO Mol Med, 2016, 8(2): 139-154. [14] Schwall CT, Greenwood VL, Alder NN. The stability and activity of respiratory Complex II is cardiolipin-dependent [J]. Biochim Biophys Acta, 2012, 1817(9): 1588-1596. [15] Gill AJ. Succinate dehydrogenase(SDH)-deficient neoplasia [J]. Histopathology, 2018, 72(1): 106-116. [16] Valianpour F, Wanders RJ, Overmars H, et al. Linoleic acid supplemention of Barth syndrome fibroblasts restores cardiolipin levels: Implications for treatment [J]. J Lipid Res, 2003, 44(3): 560-566. [17] Huang Y, Powers C, Moore V, et al. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome [J]. Orphanet J Rare Dis, 2017, 12(1): 49. [18] Wang S, Li Y, Xu Y, et al. AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome [J]. Circ Res, 2020, 126(8): 1024-1039. [19] Suzuki-Hatano S, Saha M, Rizzo SA, et al. AAV-Mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in barth syndrome [J]. Hum Gene Ther, 2019, 30(2): 139-154. [20] Povsic TJ, O’Connor CM, Henry T, et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction [J]. Am Heart J, 2011, 162(4): 654-662. [21] He Q, Harris N, Ren J, et al. Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes [J]. Oxid Med Cell Longev, 2014, 2014: 654198. doi:10.1155/2014/654198. |
[1] | PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59. |
[2] | Benkang SHI,Shouzhen CHEN,Sifeng QU,Yong WANG,Lei LIU. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116. |
[3] | Huailong ZHAO,Yan LYU,Hong ZHAO,Baotian ZHAO,Ying HAN,Jing PAN,Xiaoman DING,Chunrong WANG,Xiuyun HAN,Lanzheng LIU. Genetic characteristics and molecular variation of human rhinovirus genetype B83 in Jinan [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 68-72, 81. |
[4] | SUN Yu, CHEN Na, MA Aihua. A case of congenital disorder of glycosylation caused by SLC35A2 gene mutation [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 113-116. |
[5] | HUANG Xiuli, LIU Bingju, SUN Lifeng. Activated phosphoinositide 3-kinase δ syndrome caused by a mutation in PIK3CD gene: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 107-112. |
[6] | WANG Zhengyang, XIA Yan, SHI Kaixuan, TAO Kun, WANG Xiaojie. Effects of Trametinib on PAX8 expression in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 23-29. |
[7] | HU Sicui, SUN Qing, WANG Yibing, SUN Lili, SUI Yanxi, LI Tang. Analysis of CLCNKB gene mutation in two families with Bartter syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 64-70. |
[8] | XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101. |
[9] | LIU He, LIU Fuqiang, HOU Xinguo, CHEN Li. A study of 11β-hydroxylase defect induced by a novel CYP11B1 gene mutation in one family [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 85-89. |
[10] | LU Min, CHEN Yun, DING Botong, CHANG Yali, ZHOU Yawei, ZHAO Aiping, GUO Nongjian. Gene detection and analysis for hemophilia B among populations in Shandong Province [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 87-92. |
[11] | SUN Jie, MU Xiaoyan, DONG Xueli. Combinational and sequential effect of sunitinib and gemcitabine on K-RAS mutant A549 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 45-49. |
[12] | ZHU Famei, ZHENG Jiafa, XIE Dinghua, HU Peng. Analysis of SLC26A4 gene mutations in 5 families associated with enlarge vestibular aqueduct syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 90-95. |
[13] | SUN Jin, HAN Bo, WEI Mei-li, YANG Wen-wei, WANG Jie-zhong, LIU Yong-jiao. Mutation screening of TFAP2B gene in children with patent ductus arteriosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 72-75. |
[14] | LIU Chen-fan1, WANG Zhen-ying2, SONG Huai-dong3, PAN Chun-ming3, ZHANG Li2. Mutation screening of candidate genes causing disseminated superficial porokeratosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 93-97. |
[15] |
WANG Xue1,2, YANG Kun3, HAN Tao1, LI Wen-na1, WEI Kun-kun1, LIU Qi-ji2, LIU Xue-wu1.
NOTCH 3 heterozygous mutation causing cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in a Chinese family [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 63-. |
|